1 |
Statistical Solutions Ltd., Equiv Test 1.0, U.K. (1998)
|
2 |
Food and Drug Administration (FDA): Guidance for Industry; Waiver of in vivo bioavailability and bioequivalence study for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, Center for Drug Evaluation and Research (CDER), August (2000)
|
3 |
G.R. Corazza and M. Tonini, Levosulpiride for dyspepsia and emesis, A review of its pharmacology, efficacy and tolerability, Clin. Drug Invest., 19(2), 151-162 (2000)
DOI
ScienceOn
|
4 |
식품의약품안전청 고시 제 2001-57호, 생물학적 동등성 시험기준 (2001. 9. 5)
|
5 |
F. Bressolle and J. Bres, Dosage du sulpiride et du sultopride par chromatographie liquide a haute performance en vue de leur etude, J. Chromatogr., 341, 391-399 (1985)
DOI
ScienceOn
|
6 |
H. Tokunaga, K. Kudo, N. Jitsufuchi, Y. Ohtsuka and T. Imamura, Sensitive determination of sulpiride in human plasma by high-performance liquid chromatography, J. Chromatogr. B, 691, 203-207 (1997)
DOI
ScienceOn
|
7 |
P. Nicolas, F. Fauvelle and A. Ennachachibi, Improved determination of sulpiride in plasma bt ion-pair liquid chromatography with fluorescence detection, J. Chromatogr., 381, 393-400 (1986)
DOI
ScienceOn
|